Article
The future of sickle cell disease therapeutics rests in genomics
1 Feb 2023
Abstract excerpt
Sickle cell disease (SCD) is the most-common monogenic recessive disease in humans, annually affecting almost 300,000 newborns worldwide, 75% of whom live in Africa. Genomics research can accelerate the development of curative therapies for SCD in three ways. First, research should explore the missing heritability of foetal haemoglobin (HbF) - the strongest known modifier of SCD clinical expression - among highly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
